Before deciding to use glutathione, whether for skin whitening or other health benefits, it's important to weigh the potential risks against the benefits
All the early signs point to this paradigm shift
Obesity Landscape - Final Thoughts Dosing The GLP-1 RA obesity market, driven by injectables, has seen historic levels of success, and near-term entrants are likely to provide more dosing options within the GLP-1 or GLP-1/GIP class Weight Loss Novel drugs in development are likely to be approved within the next 5 years, with improved weight loss efficacy compared to what Wegovy and Zepbound have demonstrated Body Comp The coming years will likely see increased data on muscle preservation and the quality of weight loss with novel MoAs, even if used in combination with GLP-1/incretin-targeting agents As the obesity market matures, how will patients think about the tradeoffs between efficacy, safety, and dosing/convenience with the availability of new drugs and more data
Acknowledgments The FLOW Steering Committee comprised academic members who are authors of this paper (Katherine R
Other less common but serious side effects, such as allergic reactions (rash, swelling, difficulty breathing), require immediate medical attention
